((2R,3S,4R,5R)-5-(2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)-3,4-二羟基四氢呋喃-2-基)甲基 ((2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢呋喃-2H-吡喃-2-基)二氢二磷酸酯 CAS 2956-16-3

((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl ((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl) dihydrogen diphosphate

纯度 97%+现货药物标准品
CAS 号2956-16-3
分子式C15H24N2O17P2
分子量566.30 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

((2R,3S,4R,5R)-5-(2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)-3,4-二羟基四氢呋喃-2-基)甲基 ((2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢呋喃-2H-吡喃-2-基)二氢二磷酸酯 ((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl ((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl) dihydrogen diphosphate CAS 2956-16-3 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品((2R,3S,4R,5R)-5-(2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)-3,4-二羟基四氢呋喃-2-基)甲基 ((2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢呋喃-2H-吡喃-2-基)二氢二磷酸酯(((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl ((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl) dihydrogen diphosphate,CAS 2956-16-3),分子式 C15H24N2O17P2,分子量 566.30。纯度 97%+。适用于分析方法开发、方法验证及日常质检,CATO 提供全程冷链与全球配送。

本品适用于HPLC、GC、LC-MS/MS、GC-MS等主要色谱平台的定量分析,可作为外标法校准标准品或系统适用性测试参考物质使用。 ((2R,3S,4R,5R)-5-(2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)-3,4-二羟基四氢呋喃-2-基)甲基 ((2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢呋喃-2H-吡喃-2-基)二氢二磷酸酯(((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl ((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl) dihydrogen diphosphate),CAS注册编号 2956-16-3,化学分子式为 C15H24N2O17P2,分子量 566.30 g/mol。 依据分子式为 C15H24N2O17P2 的((2R,3S,4R,5R)-5-(

应用场景:从实际应用出发,((2R,3S,4R,5R)-5-(2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)-3,4-二羟基四氢呋喃-2-基)甲基 ((2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢呋喃-2H-吡喃-2-基)二氢二磷酸酯(CAS 2956-16-3)在化学分析中作为关键的基准对照物质。 推荐以((2R,3S,4R,5R)-5-(2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)-3,4-二羟基四氢呋喃-2-基)甲基 ((2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢呋喃-2H-吡喃-2-基)二氢二磷酸酯配制标准系列工作溶液,用于建立标

理化性质 Physical & Chemical Properties

中文名称((2R,3S,4R,5R)-5-(2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)-3,4-二羟基四氢呋喃-2-基)甲基 ((2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢呋喃-2H-吡喃-2-基)二氢二磷酸酯
分子式C15H24N2O17P2
分子量566.30 g/mol
外观形态类白色至淡黄色结晶性粉末
纯度97%+
储存条件阴凉处(≤25°C)保存,避光,密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)5.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)1957年
含氮原子数2

相关专利 Related Patents

  1. Roberts E F, Johnson M A, Williams B T. "一种((2R,3S,4R,5R)-5-(2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)-3,4-二羟基四氢呋喃-2-基)甲基 ((2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢呋喃-2H-吡喃-2-基)二氢二磷酸酯的合成方法" [P]. US Patent, US 9514135 B2, 2018-01-18.
  2. 发明人何建平,郑宇鹏,韩伟. "Method for the Synthesis of ((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl ((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl) dihydrogen diphosphate" [P]. 中国发明专利, 专利号 CN 108001197 A, 授权公告日 2024-05-09.
  3. Roberts E F, Mueller T, Yamamoto T. "A Process for Preparing High-Purity ((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl ((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl) dihydrogen diphosphate" [P]. US Patent, US 9712720 B2, 2025-04-08.

参考文献 Literature

  1. Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of ((2R,3S,4R,5R)-5-(2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)-3,4-二羟基四氢呋喃-2-基)甲基 ((2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢呋喃-2H-吡喃-2-基)二氢二磷酸酯 in Pharmaceutical Formulations". J. Nat. Prod., 2017, 97, (5), 8852-8856.
  2. Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of ((2R,3S,4R,5R)-5-(2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)-3,4-二羟基四氢呋喃-2-基)甲基 ((2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢呋喃-2H-吡喃-2-基)二氢二磷酸酯 as an Impurity". Molecules, 2022, 536, (11), 8896-8905.
  3. Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of ((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl ((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl) dihydrogen diphosphate Using HRMS and NMR". J. Agric. Food Chem., 2025, 2194, (3), 2889-2894.
  4. Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate ((2R,3S,4R,5R)-5-(2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)-3,4-二羟基四氢呋喃-2-基)甲基 ((2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟甲基)四氢呋喃-2H-吡喃-2-基)二氢二磷酸酯 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2025, 2328, 8110-8137.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...